Acadia Healthcare (NASDAQ:ACHC) Shares Pass Above Two Hundred Day Moving Average – What’s Next?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $19.01 and traded as high as $26.65. Acadia Healthcare shares last traded at $26.61, with a volume of 2,039,257 shares traded.

Analyst Upgrades and Downgrades

ACHC has been the topic of a number of recent research reports. Guggenheim decreased their target price on Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating on the stock in a report on Monday, February 23rd. Barclays lifted their target price on Acadia Healthcare from $14.00 to $20.00 and gave the stock an “equal weight” rating in a report on Tuesday, March 3rd. Leerink Partners lifted their target price on Acadia Healthcare from $14.00 to $22.00 and gave the stock a “market perform” rating in a report on Thursday, February 26th. Mizuho decreased their target price on Acadia Healthcare from $22.00 to $17.00 and set a “neutral” rating for the company in a research report on Thursday, December 18th. Finally, TD Cowen raised their target price on Acadia Healthcare from $22.00 to $24.00 and gave the stock a “buy” rating in a research report on Thursday, February 26th. Seven equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $21.15.

Acadia Healthcare Trading Up 0.2%

The firm has a market cap of $2.45 billion, a price-to-earnings ratio of -2.18, a PEG ratio of 8.97 and a beta of 0.71. The company has a 50-day moving average price of $21.78 and a 200 day moving average price of $19.01. The company has a quick ratio of 1.55, a current ratio of 1.55 and a debt-to-equity ratio of 1.27.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, February 25th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of $0.03 by $0.04. The business had revenue of $821.46 million during the quarter, compared to analysts’ expectations of $800.10 million. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.Acadia Healthcare’s revenue was up 6.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.64 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. As a group, research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Institutional Trading of Acadia Healthcare

A number of institutional investors have recently bought and sold shares of ACHC. Goldman Sachs Group Inc. boosted its position in Acadia Healthcare by 417.8% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock valued at $67,099,000 after purchasing an additional 3,815,471 shares during the last quarter. Jefferies Financial Group Inc. acquired a new stake in Acadia Healthcare during the fourth quarter valued at $47,960,000. Wellington Management Group LLP boosted its position in Acadia Healthcare by 24.9% during the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after purchasing an additional 2,350,760 shares during the last quarter. Invenomic Capital Management LP boosted its position in Acadia Healthcare by 71.0% during the fourth quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock valued at $46,998,000 after purchasing an additional 1,375,647 shares during the last quarter. Finally, Deerfield Management Company L.P. acquired a new stake in Acadia Healthcare during the third quarter valued at $29,440,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.